Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02158130 · ClinicalTrials.gov registry record
Effects of Aerobic Exercise Detraining
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 25
- Enrollment target
NCT02158130: Completed study, sponsored by Pennington Biomedical Research Center.
NCT02158130 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02158130 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The proposed study seeks to better understand the role of body weight, energy expenditure, and energy intake as mechanisms of body weight gain during detraining following aerobic exercise. It is hypothesized that participants in the higher dose exercise group will have greater body weight gain compared to the lower exercise dose and control group from wk 24 to wk 76 follow-up.
Primary Outcome
Fasting body weight
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-03 |
What the finished NCT02158130 record still lists
NCT02158130 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02158130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02158130 about?
NCT02158130 is a clinical study titled "Effects of Aerobic Exercise Detraining". The proposed study seeks to better understand the role of body weight, energy expenditure, and energy intake as mechanisms of body weight gain during detraining following aerobic exercise. It is hypothesized that participants in the higher dose exercise group will have greater body weight gain compa...
What is the current status of trial NCT02158130?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2014-09. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT02158130?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia